Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$164.32 - $212.72 $977,539 - $1.27 Million
-5,949 Closed
0 $0
Q4 2020

Feb 19, 2021

BUY
$130.46 - $172.63 $776,106 - $1.03 Million
5,949 New
5,949 $991,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track 3 D/L Capital Management, LLC Portfolio

Follow 3 D/L Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 3 D/L Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 3 D/L Capital Management, LLC with notifications on news.